1. AstraZeneca gets FDA OK for Imfinzi in small-cell lung cancer— Regeneron and Sanofi treat first person outside US in coronavirus drug trial — FDA accepts Roche's NDA for Xofluza to treat flu in children — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

BMS CEO-James M. Cornelius

Discussion in 'Zymogenetics' started by Anonymous, Jan 6, 2011 at 9:15 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    We at Zymo triple dog dare you to lay off more of us--BMS needs a new CEO who knows what he is doing. What is your excuse for your incompetence?
     

  2. Anonymous

    Anonymous Guest

    Just lay them all off and sell off the company for parts. There's nothing worth saving!
     
  3. Anonymous

    Anonymous Guest

    Jimbo is the joke of the industry--LMFAO!!
     
  4. Anonymous

    Anonymous Guest

    The only thing worth saving of former Zymo are the IP. The Zymo brains and people are useless. They are just a bunch of lazy robots who should not get paid more than half of what they are earning now. If BSM has to trim down on expense, this is an easy group to start with.
     
  5. Anonymous

    Anonymous Guest

    Agreed! The talent that gave Zymo their IP and useful products are all long gone. What remains are the treacherous politicians who kept their jobs by sacrificing the good workers. Their only talent is procuring resources for themselves.
     
  6. Anonymous

    Anonymous Guest

    so what is really happening? Did BMS lay off zymo reps?
     
  7. Anonymous

    Anonymous Guest

    Don't know about reps, but we are being peeled off a few at a time at the home office!!
     
  8. Anonymous

    Anonymous Guest

    Not yet, they are too busy laying off there own hospital reps, but I am sure it will head our way sooner or later. The whole integration thing is just a smoke screen to a massive layoff or the division being sold off. Personally Zymo was headed down the whole big pharma shit hole long before they bought us.
     
  9. Anonymous

    Anonymous Guest

    We, the best of what Zymo has to offer, are the real brains behind Reco and other pipeline candidates. The riff raff was either canned or they left for other jobs.

    In our opinion, BMS is a big joke and should spin us off as an independent company, like we used to be...BMS as pharma needs to be broken up and sold off!
     
  10. Anonymous

    Anonymous Guest

    Yeah, in those last few years after Reco was approved, the stock became a single-digit midget (going to down the the 2's), and never recovered. So much for your tutelage...
     
  11. Anonymous

    Anonymous Guest

    A Zymonite calling BMS a big joke? Since when can a flea judge the dog it is feeding on?